KLF5 promotes cervical cancer proliferation, migration and invasion in a manner partly dependent on TNFRSF11a expression
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
KLF5 promotes cervical cancer proliferation, migration and invasion in a manner partly dependent on TNFRSF11a expression
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-10
DOI
10.1038/s41598-017-15979-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bisphenol A Induces Migration through a GPER-, FAK-, Src-, and ERK2-Dependent Pathway in MDA-MB-231 Breast Cancer Cells
- (2016) Rocio Castillo Sanchez et al. CHEMICAL RESEARCH IN TOXICOLOGY
- KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2
- (2015) L Jia et al. ONCOGENE
- The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1
- (2015) Chunyan Wang et al. Oncotarget
- Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe
- (2012) Wiebren A. Tjalma et al. INTERNATIONAL JOURNAL OF CANCER
- Clinico-epigenetic combination including quantitative methylation value of DKK3 augments survival prediction of the patient with cervical cancer
- (2012) Woong-Sun Kang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells
- (2012) KENTA MASUDA et al. ONCOLOGY REPORTS
- Evidence for a link between TNFRSF11A and risk of breast cancer
- (2011) Núria Bonifaci et al. BREAST CANCER RESEARCH AND TREATMENT
- Estrogen Regulates Tumor Growth Through a Nonclassical Pathway that Includes the Transcription Factors ER and KLF5
- (2011) Y. Nakajima et al. Science Signaling
- A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results
- (2010) Jaime Coronel et al. MEDICAL ONCOLOGY
- Haploinsufficiency of Kruppel-Like Factor 5 Rescues the Tumor-Initiating Effect of the ApcMin Mutation in the Intestine
- (2009) B. B. McConnell et al. CANCER RESEARCH
- Angiotensin II Stimulates KLF5 Phosphorylation and its Interaction with c-Jun Leading to Suppression of p21 Expression in Vascular Smooth Muscle Cells
- (2009) M. He et al. JOURNAL OF BIOCHEMISTRY
- KLF5 Promotes Breast Cell Survival Partially through Fibroblast Growth Factor-binding Protein 1-pERK-mediated Dual Specificity MKP-1 Protein Phosphorylation and Stabilization
- (2009) Rong Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Krüppel-like Factor 5 Shows Proliferation-specific Roles in Vascular Remodeling, Direct Stimulation of Cell Growth, and Inhibition of Apoptosis
- (2009) Toru Suzuki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis
- (2009) Niladri Ganguly et al. JOURNAL OF BIOSCIENCES
- Up-Regulation of Kruppel-Like Factor 5 in Pancreatic Cancer Is Promoted by Interleukin-1 Signaling and Hypoxia-Inducible Factor-1
- (2009) A. Mori et al. MOLECULAR CANCER RESEARCH
- Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1
- (2009) H -Q Zheng et al. ONCOGENE
- Osteosarcoma Development and Stem Cell Differentiation
- (2008) Ni Tang et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Krüppel-like Factor 5 Controls Keratinocyte Migration via the Integrin-linked Kinase
- (2008) Yizeng Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now